Walgreens Boots Alliance (NASDAQ:WBA) was upgraded by investment analysts at ValuEngine from a “hold” rating to a “buy” rating in a research report issued to clients and investors on Thursday, January 4th.

A number of other equities analysts have also recently weighed in on WBA. Jefferies Group reiterated a “buy” rating and set a $95.00 price target on shares of Walgreens Boots Alliance in a report on Thursday, September 7th. Needham & Company LLC reiterated a “buy” rating and set a $94.00 price target on shares of Walgreens Boots Alliance in a report on Sunday, September 10th. BidaskClub cut Walgreens Boots Alliance from a “hold” rating to a “sell” rating in a report on Tuesday, September 12th. Royal Bank of Canada started coverage on Walgreens Boots Alliance in a report on Tuesday, September 19th. They set an “outperform” rating and a $96.00 price target for the company. Finally, Raymond James Financial reiterated a “market perform” rating on shares of Walgreens Boots Alliance in a report on Wednesday, September 27th. Ten analysts have rated the stock with a hold rating, fourteen have issued a buy rating and one has given a strong buy rating to the stock. The stock currently has an average rating of “Buy” and a consensus price target of $86.00.

How to Become a New Pot Stock Millionaire

Shares of Walgreens Boots Alliance (WBA) traded up $1.12 during trading hours on Thursday, reaching $80.27. The company’s stock had a trading volume of 6,248,648 shares, compared to its average volume of 5,560,000. The company has a current ratio of 0.96, a quick ratio of 0.47 and a debt-to-equity ratio of 0.48. The stock has a market cap of $79,520.00, a PE ratio of 22.17, a P/E/G ratio of 1.34 and a beta of 1.22. Walgreens Boots Alliance has a 12 month low of $63.82 and a 12 month high of $88.00.

Walgreens Boots Alliance (NASDAQ:WBA) last issued its earnings results on Thursday, January 4th. The pharmacy operator reported $1.28 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $1.27 by $0.01. The company had revenue of $30.74 billion during the quarter, compared to analysts’ expectations of $30.39 billion. Walgreens Boots Alliance had a return on equity of 19.15% and a net margin of 3.19%. The firm’s quarterly revenue was up 7.9% on a year-over-year basis. During the same period in the prior year, the business earned $1.10 EPS. analysts predict that Walgreens Boots Alliance will post 5.71 EPS for the current year.

Walgreens Boots Alliance declared that its Board of Directors has approved a share repurchase plan on Wednesday, October 25th that permits the company to buyback $1.00 billion in shares. This buyback authorization permits the pharmacy operator to repurchase shares of its stock through open market purchases. Stock buyback plans are often a sign that the company’s board of directors believes its stock is undervalued.

In other Walgreens Boots Alliance news, Director William C. Foote sold 2,736 shares of the stock in a transaction dated Thursday, November 2nd. The stock was sold at an average price of $67.37, for a total value of $184,324.32. Following the sale, the director now owns 16,415 shares of the company’s stock, valued at approximately $1,105,878.55. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, insider Stefano Pessina purchased 98,858 shares of Walgreens Boots Alliance stock in a transaction on Monday, January 15th. The stock was bought at an average cost of $76.07 per share, for a total transaction of $7,520,128.06. The disclosure for this purchase can be found here. Company insiders own 14.80% of the company’s stock.

Hedge funds have recently bought and sold shares of the business. Hudock Capital Group LLC raised its position in shares of Walgreens Boots Alliance by 0.5% during the 2nd quarter. Hudock Capital Group LLC now owns 1,306 shares of the pharmacy operator’s stock worth $102,000 after acquiring an additional 6 shares in the last quarter. Westside Investment Management Inc. raised its position in shares of Walgreens Boots Alliance by 10.4% during the 2nd quarter. Westside Investment Management Inc. now owns 1,325 shares of the pharmacy operator’s stock worth $102,000 after acquiring an additional 125 shares in the last quarter. Zions Bancorporation raised its position in shares of Walgreens Boots Alliance by 983.3% during the 3rd quarter. Zions Bancorporation now owns 1,365 shares of the pharmacy operator’s stock worth $105,000 after acquiring an additional 1,239 shares in the last quarter. IHT Wealth Management LLC raised its position in shares of Walgreens Boots Alliance by 46.3% during the 2nd quarter. IHT Wealth Management LLC now owns 6,946 shares of the pharmacy operator’s stock worth $135,000 after acquiring an additional 2,199 shares in the last quarter. Finally, Bristlecone Advisors LLC acquired a new stake in shares of Walgreens Boots Alliance during the 3rd quarter worth about $135,000. 61.17% of the stock is currently owned by institutional investors.

ILLEGAL ACTIVITY NOTICE: “Walgreens Boots Alliance (WBA) Upgraded by ValuEngine to “Buy”” was originally reported by Marea Informative and is owned by of Marea Informative. If you are accessing this report on another publication, it was copied illegally and republished in violation of United States and international copyright and trademark legislation. The original version of this report can be read at https://www.mareainformativa.com/2018/01/29/walgreens-boots-alliance-wba-lifted-to-buy-at-valuengine-updated-updated-updated.html.

Walgreens Boots Alliance Company Profile

Walgreens Boots Alliance, Inc (Walgreens Boots Alliance) is a holding company. The Company is a global pharmacy-led, health and wellbeing enterprise. Walgreens Boots Alliance operates through three divisions, including Retail Pharmacy USA, Retail Pharmacy International and Pharmaceutical Wholesale. The Company’s products are marketed under a number of brands, which include No7, the Botanics range, Almus (generic medicines), Boots Pharmaceuticals and Soap & Glory (bathing and beauty brand).

To view ValuEngine’s full report, visit ValuEngine’s official website.

Analyst Recommendations for Walgreens Boots Alliance (NASDAQ:WBA)

Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.